[CAS NO. 2446803-91-2] IL-17modulator1disodium
PRODUCTS SPECIFICATIONS [2446803-91-2]
DESCRIPTION [2446803-91-2]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 628.57 |
| Molecular Formula | C28H35N6Na2O6P |
| SMILES | O=C(C1=CC=NN1C(C)C)N[C@H](C(NC2=CC=C(C3=C(N(N=C3C)COP(O[Na])(O[Na])=O)C)C=C2)=O)C(C4CC4)C5CC5 |
Summary
IL-17 modulator 1 (disodium) is an orally active, highly efficacious IL-17 modulator extracted from patent WO 2020127685. IL-17 modulator 1 (disodium) can be used for the research of diseases including psoriasis, ankylosing spondylitis and psoriatic arthritis [1] .
IC50 & Target
|
IL-17 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 20 mg/mL ( 31.82 mM ; ultrasonic and warming and heat to 80°C)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.5909 mL | 7.9546 mL | 15.9091 mL |
| 5 mM | 0.3182 mL | 1.5909 mL | 3.1818 mL |
| 10 mM | 0.1591 mL | 0.7955 mL | 1.5909 mL |
References